Literature DB >> 8847558

Delayed, transient encephalopathy after marrow transplantation: case reports and MRI findings in four patients.

H I Tahsildar1, B F Remler, R J Creger, B W Cooper, S M Snodgrass, R W Tarr, H M Lazarus.   

Abstract

Subacute encephalopathy developed in four patients within one to two months after undergoing high-dose chemotherapy and bone marrow transplantation or peripheral blood progenitor (stem) cell transplantation for breast cancer, acute myeloid leukemia, and non-Hodgkin's lymphoma. None of the patients had previously known neurologic disorders, central nervous tumor or infection. Two patients presented with generalized tonic, clonic seizures, and two with confusion and lethargy. In all patients lumbar puncture and CT scans of the brain were normal, while magnetic resonance imaging (MRI) demonstrated multifocal predominantly white matter lesions. Phenytoin therapy was given to the two patients with seizures and all four patients improved without specific therapeutic intervention. Repeat MRIs became normal within three months. We report a delayed and transient encephalopathy which appears to be a unique complication of high-dose cytotoxic chemotherapy. The corresponding brain lesions may not be appreciated on CT scans, suggesting an expanded role for MRI studies in patients who develop neurologic findings while undergoing high-dose cytotoxic therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8847558     DOI: 10.1007/bf00165481

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  65 in total

1.  99Tcm-HMPAO SPECT and magnetic resonance studies in L-asparaginase induced cerebrovascular accident.

Authors:  N K Foreman; H H Mahmoud; J W Langston
Journal:  Br J Radiol       Date:  1992-01       Impact factor: 3.039

Review 2.  High-dose N,N',N"-triethylenethiophosphoramide (thiotepa) with autologous bone marrow transplantation: phase I studies.

Authors:  S N Wolff; R H Herzig; J W Fay; C F LeMaistre; R A Brown; D Frei-Lahr; S Stranjord; L Giannone; P Coccia; J L Weick
Journal:  Semin Oncol       Date:  1990-02       Impact factor: 4.929

Review 3.  Cytarabine and neurologic toxicity.

Authors:  W J Baker; G L Royer; R B Weiss
Journal:  J Clin Oncol       Date:  1991-04       Impact factor: 44.544

4.  Cortical blindness and white matter lesions in a patient receiving FK506 after liver transplantation.

Authors:  L A Shutter; J P Green; N J Newman; M A Hooks; R D Gordon
Journal:  Neurology       Date:  1993-11       Impact factor: 9.910

Review 5.  Neurotoxicity of commonly used antineoplastic agents (first of two parts).

Authors:  H D Weiss; M D Walker; P H Wiernik
Journal:  N Engl J Med       Date:  1974-07-11       Impact factor: 91.245

6.  Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

Authors:  P C de Groen; A J Aksamit; J Rakela; G S Forbes; R A Krom
Journal:  N Engl J Med       Date:  1987-10-01       Impact factor: 91.245

7.  Acute neurologic dysfunction after high-dose etoposide therapy for malignant glioma.

Authors:  R S Leff; J M Thompson; M B Daly; D B Johnson; E A Harden; R J Mercier; G L Messerschmidt
Journal:  Cancer       Date:  1988-07-01       Impact factor: 6.860

8.  Cerebral blindness and encephalopathy with cyclosporin A toxicity.

Authors:  A M Rubin; H Kang
Journal:  Neurology       Date:  1987-06       Impact factor: 9.910

9.  Association between cyclosporin neurotoxicity and hypomagnesaemia.

Authors:  C B Thompson; C H June; K M Sullivan; E D Thomas
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

Review 10.  Taxol: a novel investigational antimicrotubule agent.

Authors:  E K Rowinsky; L A Cazenave; R C Donehower
Journal:  J Natl Cancer Inst       Date:  1990-08-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.